D. Scott Coward - 06 Oct 2026 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Reporting relationship: Director
Issuer ticker: HUMA
Reported as of: 06 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Oct 2026, 16:06:03 UTC
Prior SEC filing: 28 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Scott D. Coward by Dale A. Sander as Attorney-in-Fact

Key filing fact

D. Scott Coward filed Form 4 for Humacyte, Inc. (HUMA) on 07 Oct 2026.

Key facts

This page summarizes D. Scott Coward's Form 4 filing for Humacyte, Inc. (HUMA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Oct 2026, 16:06.

Change

Previous filing in this sequence was filed on 28 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001247296 Primary reporting owner

COWARD D SCOTT

Relationship: Director
Address: 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Signature: /s/ Scott D. Coward by Dale A. Sander as Attorney-in-Fact
Signature date: 07 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUMA transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares: +125,000
Change %
Price: $0.000000^*
Shares after: 125,000
Date: 06 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 125,000
Exercise price: $0.4780
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The first 25% of the option becomes exercisable on October 6, 2027, after which 1/48 of the option becomes exercisable on the 6th day of each month thereafter, with the option becoming fully vested on October 6, 2030.